Title : Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.

Pub. Date : 1995 Dec

PMID : 8542954






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction. Oligonucleotides ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens
2 As the BCR-ABL rearrangement is specific to leukemic cells, selective inhibition of leukemic cell growth by BCR-ABL antisense oligonucleotides (ASO) has been reported in vitro for CML patients and cell lines. Oligonucleotides ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens
3 As the BCR-ABL rearrangement is specific to leukemic cells, selective inhibition of leukemic cell growth by BCR-ABL antisense oligonucleotides (ASO) has been reported in vitro for CML patients and cell lines. Oligonucleotides ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens